看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 53.6x - 59.3x | 56.4x |
| Selected Fwd P/E Multiple | 36.0x - 39.8x | 37.9x |
| Fair Value | kr497.12 - kr549.45 | kr523.28 |
| Upside | -1.0% - 9.5% | 4.2% |
| Benchmarks | - | Full Ticker |
| Gubra A/S | - | CPSE:GUBRA |
| Stevanato Group S.p.A. | - | DB:87N |
| Qiagen N.V. | - | DB:QIA |
| Sartorius Aktiengesellschaft | - | DB:SRT |
| hVIVO plc | - | DB:CRO |
| ChemoMetec A/S | - | CPSE:CHEMM |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| GUBRA | 87N | QIA | SRT | CRO | CHEMM | |||
| CPSE:GUBRA | DB:87N | DB:QIA | DB:SRT | DB:CRO | CPSE:CHEMM | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | 24.6% | NM- | -11.7% | NM- | 26.6% | ||
| 3Y CAGR | NM- | -4.3% | -45.4% | -35.9% | NM- | 15.5% | ||
| Latest Twelve Months | 18.0% | 9.8% | 413.6% | 32.8% | -33.9% | 17.6% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -6.8% | 13.5% | 16.1% | 12.0% | -13.2% | 34.6% | ||
| Prior Fiscal Year | -21.7% | 13.4% | 17.4% | 6.1% | 27.5% | 40.2% | ||
| Latest Fiscal Year | -13.7% | 10.7% | 4.2% | 2.5% | 16.1% | 33.4% | ||
| Latest Twelve Months | -13.7% | 11.8% | 18.3% | 3.0% | 16.1% | 36.8% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -113.5x | 21.4x | 11.0x | 21.6x | 3.1x | 37.7x | ||
| Price / LTM Sales | 20.7x | 4.5x | 5.2x | 3.4x | 1.1x | 18.6x | ||
| LTM P/E Ratio | -150.8x | 38.2x | 28.4x | 114.3x | 6.9x | 50.6x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -150.8x | 28.4x | 114.3x | |||||
| Historical LTM P/E Ratio | 37.9x | 90.6x | 180.8x | |||||
| Selected P/E Multiple | 53.6x | 56.4x | 59.3x | |||||
| (x) LTM Net Income | 169 | 169 | 169 | |||||
| (=) Equity Value | 9,066 | 9,543 | 10,020 | |||||
| (/) Shares Outstanding | 17.4 | 17.4 | 17.4 | |||||
| Implied Value Range | 520.95 | 548.37 | 575.79 | |||||
| FX Rate: DKK/DKK | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 520.95 | 548.37 | 575.79 | 502.00 | ||||
| Upside / (Downside) | 3.8% | 9.2% | 14.7% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | GUBRA | 87N | QIA | SRT | CRO | CHEMM | |
| Value of Common Equity | 5,688 | 4,996 | 10,504 | 12,867 | 63 | 8,736 | |
| (/) Shares Outstanding | 16.3 | 273.0 | 216.8 | 77.9 | 680.4 | 17.4 | |
| Implied Stock Price | 348.80 | 18.30 | 48.44 | 165.20 | 0.09 | 502.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.17 | 1.00 | 0.86 | 1.00 | |
| Implied Stock Price (Trading Cur) | 348.80 | 18.30 | 41.50 | 165.20 | 0.11 | 502.00 | |
| Trading Currency | DKK | EUR | EUR | EUR | EUR | DKK | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.17 | 1.00 | 0.86 | 1.00 | |